Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $102 | $58 | $75 |
| Short-Term Investments | $121 | $83 | $27 | $10 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $5 | $6 | $7 |
| Total Curr. Assets | $175 | $190 | $90 | $92 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $60 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $12 | $28 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $62 | $3 | $14 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $237 | $194 | $104 | $122 |
| Liabilities | – | – | – | – |
| Payables | $7 | $4 | $6 | $7 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $18 | $8 | $7 | $7 |
| Other Curr. Liab. | $66 | $14 | $12 | $12 |
| Total Curr. Liab. | $90 | $25 | $25 | $27 |
| LT Debt | $24 | $24 | $1 | $1 |
| Deferred Rev, NC | $1 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $25 | $24 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $115 | $49 | $26 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$406 | -$372 | -$344 | -$314 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $528 | $518 | $423 | $409 |
| Total Equity | $122 | $145 | $79 | $94 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $237 | $194 | $104 | $122 |
| Net Debt | -$20 | -$79 | -$57 | -$74 |